Elanco Animal Health (ELAN) Enterprise Value (2017 - 2026)

Elanco Animal Health has disclosed Enterprise Value across 10 years of filings, most recently posting -$428.0 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$428.0 million, up 12.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$428.0 million (up 12.11% YoY), and the FY2025 annual result was -$545.0 million, down 16.45% from the prior year.
• Enterprise Value came in at -$428.0 million for Q1 2026 at Elanco Animal Health, up from -$545.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$318.0 million in Q1 2023 to a low of -$545.0 million in Q4 2025.
• The 5-year median for Enterprise Value is -$428.0 million (2026), against an average of -$428.4 million.
• Across the five-year window, Enterprise Value jumped 45.92% in 2022 and sank 41.16% in 2025, its largest moves.
• Elanco Animal Health's Enterprise Value stood at -$345.0 million in 2022, then decreased by 2.03% to -$352.0 million in 2023, then slumped by 32.95% to -$468.0 million in 2024, then retreated by 16.45% to -$545.0 million in 2025, then climbed by 21.47% to -$428.0 million in 2026.
• The last three Enterprise Value figures came in at -$428.0 million (Q1 2026), -$545.0 million (Q4 2025), and -$505.0 million (Q3 2025), per Business Quant data.